These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8817417)

  • 1. High dose chemotherapy with autologous stem cell rescue for patients with medulloblastoma.
    Dunkel IJ; Finlay JL
    J Neurooncol; 1996 Jul; 29(1):69-74. PubMed ID: 8817417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group.
    Dunkel IJ; Boyett JM; Yates A; Rosenblum M; Garvin JH; Bostrom BC; Goldman S; Sender LS; Gardner SL; Li H; Allen JC; Finlay JL
    J Clin Oncol; 1998 Jan; 16(1):222-8. PubMed ID: 9440746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastoma.
    Dunkel IJ; Gardner SL; Garvin JH; Goldman S; Shi W; Finlay JL
    Neuro Oncol; 2010 Mar; 12(3):297-303. PubMed ID: 20167818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of high-dose chemotherapy and autologous stem cell transplantation in patients with relapsed medulloblastoma: a report on the Korean Society for Pediatric Neuro-Oncology (KSPNO)-S-053 study.
    Park JE; Kang J; Yoo KH; Sung KW; Koo HH; Lim DH; Shin HJ; Kang HJ; Park KD; Shin HY; Kim IH; Cho BK; Im HJ; Seo JJ; Park HJ; Park BK; Ahn HS
    J Korean Med Sci; 2010 Aug; 25(8):1160-6. PubMed ID: 20676326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors.
    Pérez-Martínez A; Lassaletta A; González-Vicent M; Sevilla J; Díaz MA; Madero L
    J Neurooncol; 2005 Jan; 71(1):33-8. PubMed ID: 15719272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocols.
    Dhall G; Grodman H; Ji L; Sands S; Gardner S; Dunkel IJ; McCowage GB; Diez B; Allen JC; Gopalan A; Cornelius AS; Termuhlen A; Abromowitch M; Sposto R; Finlay JL
    Pediatr Blood Cancer; 2008 Jun; 50(6):1169-75. PubMed ID: 18293379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian function in survivors of childhood medulloblastoma: Impact of reduced dose craniospinal irradiation and high-dose chemotherapy with autologous stem cell rescue.
    Balachandar S; Dunkel IJ; Khakoo Y; Wolden S; Allen J; Sklar CA
    Pediatr Blood Cancer; 2015 Feb; 62(2):317-321. PubMed ID: 25346052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.
    Gajjar A; Chintagumpala M; Ashley D; Kellie S; Kun LE; Merchant TE; Woo S; Wheeler G; Ahern V; Krasin MJ; Fouladi M; Broniscer A; Krance R; Hale GA; Stewart CF; Dauser R; Sanford RA; Fuller C; Lau C; Boyett JM; Wallace D; Gilbertson RJ
    Lancet Oncol; 2006 Oct; 7(10):813-20. PubMed ID: 17012043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of high-dose chemotherapy and stem cell rescue in the treatment of malignant brain tumors.
    Finlay JL
    Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S1-5. PubMed ID: 8971398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [High-dose chemotherapy in relapse of medulloblastoma in young children].
    Dupuis-Girod S; Hartmann O; Benhamou E; Doz F; Mechinaud F; Bouffet E; Coze C; Kalifa C
    Bull Cancer; 1997 Mar; 84(3):264-72. PubMed ID: 9207872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of intensive chemotherapy in the treatment of medulloblastoma/primitive neuroectodermal tumor in children].
    Konoplia NE; Strongin IuS; Talabaev MV; Aleĭnikova OV
    Vopr Onkol; 2008; 54(2):157-63. PubMed ID: 18522163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma.
    Chi SN; Gardner SL; Levy AS; Knopp EA; Miller DC; Wisoff JH; Weiner HL; Finlay JL
    J Clin Oncol; 2004 Dec; 22(24):4881-7. PubMed ID: 15611503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of high-dose chemotherapy for recurrent medulloblastoma and other CNS primitive neuroectodermal tumors.
    Gajjar A; Pizer B
    Pediatr Blood Cancer; 2010 Apr; 54(4):649-51. PubMed ID: 20146223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor.
    Sung KW; Yoo KH; Cho EJ; Koo HH; Lim DH; Shin HJ; Ahn SD; Ra YS; Choi ES; Ghim TT
    Pediatr Blood Cancer; 2007 Apr; 48(4):408-15. PubMed ID: 17066462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful Use of Dose Dense Neoadjuvant Chemotherapy and Sodium Valproate with Minimal Toxicity in an Infant with Medulloblastoma in Extremely Poor General Condition.
    Gupta A; Kumar A; Abrari A; Patir R; Vaishya S
    World Neurosurg; 2016 Sep; 93():485.e1-5. PubMed ID: 27450977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
    Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
    Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term Outcomes of Protocol-Based Treatment for Newly Diagnosed Medulloblastoma.
    Ahn WK; Hahn SM; Yoon HI; Lee J; Park EK; Shim KW; Kim DS; Suh CO; Kim SH; Lyu CJ; Han JW
    Cancer Res Treat; 2024 Apr; 56(2):652-664. PubMed ID: 38037318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of patients of high-risk group of medulloblastoma with the adjuvant lomustine, cisplatin, and vincristine chemotherapy.
    Rutkauskiene G; Labanauskas L
    Medicina (Kaunas); 2005; 41(12):1026-34. PubMed ID: 16401959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose chemotherapy in children with newly-diagnosed medulloblastoma.
    Grill J; Dufour C; Kalifa C
    Lancet Oncol; 2006 Oct; 7(10):787-9. PubMed ID: 17012036
    [No Abstract]   [Full Text] [Related]  

  • 20. Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma?
    Dupuis-Girod S; Hartmann O; Benhamou E; Doz F; Mechinaud F; Bouffet E; Coze C; Kalifa C
    J Neurooncol; 1996 Jan; 27(1):87-98. PubMed ID: 8699230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.